tiprankstipranks
Century Therapeutics, Inc. (IPSC)
NASDAQ:IPSC
US Market
IPSC
Century Therapeutics
RESEARCH TOOLSreports
Want to see IPSC full AI Analyst Report?

Century Therapeutics (IPSC) Income Statement

270 Followers

Century Therapeutics Income Statement

Last quarter (Q4 2025), Century Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Century Therapeutics's net income was $-19.18M. See Century Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 109.16M$ 6.59M$ 2.23M$ 5.20M$ 0.00
Gross Profit
$ 96.06M$ 6.59M$ 2.23M$ 5.20M$ -4.58M
Operating Expenses
$ 111.10M$ 144.73M$ 148.78M$ 139.03M$ 90.30M
Depreciation and Amortization
$ 13.10M$ 13.30M$ 13.04M$ 8.44M$ 4.58M
EBITDA
$ -1.94M$ -111.47M$ -121.21M$ -121.20M$ -89.92M
Operating Income
$ -15.04M$ -138.14M$ -146.55M$ -133.83M$ -94.88M
Other Income/Expenses
$ 5.39M$ 13.36M$ 11.75M$ 2.99M$ -898.00K
Pretax Income
$ -9.65M$ -124.78M$ -134.79M$ -130.84M$ -95.78M
Net Income
$ -9.58M$ -126.57M$ -136.67M$ -130.93M$ -95.82M
Per Share Metrics
Basic EPS
$ -0.11$ -1.61$ -2.30$ -2.27$ -1.74
Diluted EPS
$ -0.11$ -1.61$ -2.30$ -2.27$ -1.74
Weighted Average Shares Outstanding
 86.56M 78.65M 59.31M 57.76M 55.01M
Weighted Average Shares Outstanding (Diluted)
 86.56M 78.65M 59.31M 57.76M 55.01M
Currency in USD

Century Therapeutics Earnings and Revenue History